Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote GBp

ConvaTec Group PLC (CTEC.L)

Compare
257.20
-1.20
(-0.46%)
At close: March 31 at 4:35:24 PM GMT+1
Loading Chart for CTEC.L
  • Previous Close 258.40
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 295.20
  • Volume 165,846
  • Avg. Volume 5,512,410
  • Market Cap (intraday) 5.258B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) 36.74
  • EPS (TTM) 0.07
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield 0.05 (1.96%)
  • Ex-Dividend Date Apr 17, 2025
  • 1y Target Est 297.98

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

www.convatecgroup.com

10,489

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CTEC.L

View More

Performance Overview: CTEC.L

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

CTEC.L
16.27%
FTSE 100 (^FTSE)
5.01%

1-Year Return

CTEC.L
10.18%
FTSE 100 (^FTSE)
7.92%

3-Year Return

CTEC.L
19.35%
FTSE 100 (^FTSE)
14.20%

5-Year Return

CTEC.L
38.05%
FTSE 100 (^FTSE)
51.32%

Compare To: CTEC.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CTEC.L

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    5.28B

  • Enterprise Value

    6.16B

  • Trailing P/E

    35.98

  • Forward P/E

    19.57

  • PEG Ratio (5yr expected)

    1.73

  • Price/Sales (ttm)

    3.01

  • Price/Book (mrq)

    4.05

  • Enterprise Value/Revenue

    3.49

  • Enterprise Value/EBITDA

    14.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.32%

  • Return on Assets (ttm)

    6.06%

  • Return on Equity (ttm)

    11.27%

  • Revenue (ttm)

    2.29B

  • Net Income Avi to Common (ttm)

    190.5M

  • Diluted EPS (ttm)

    0.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    65.1M

  • Total Debt/Equity (mrq)

    71.18%

  • Levered Free Cash Flow (ttm)

    309.75M

Research Analysis: CTEC.L

View More

Company Insights: CTEC.L

Research Reports: CTEC.L

View More

People Also Watch